<DOC>
	<DOCNO>NCT01236534</DOCNO>
	<brief_summary>The purpose study assess safe effective drug Lubiprostone people Multiple Sclerosis ( MS ) moderate severe MS-associated constipation . Lubiprostone approve FDA treatment two common type constipation adult , chronic idiopathic constipation irritable bowel syndrome .</brief_summary>
	<brief_title>Lubiprostone Patients With Multiple Sclerosis Associated Constipation</brief_title>
	<detailed_description>Multiple Sclerosis ( MS ) disorder body 's immune system affect central nervous system . Normally , nerve fiber carry electrical impulse spinal cord , provide communication brain bowel . In people MS , cover around nerve fiber deteriorates , cause nerve impulse slow stop . result , patient MS may experience constipation .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Multiple Sclerosis Chronic Constipation define &lt; 3 spontaneous bowel movement per week history confirm diary 14 day washout period . Women childbearing potential must agree use adequate birth control . history clinically significant medical psychiatric disorder suicidal ideation . Subjects suspicion mechanical bowel obstruction clinical evaluation prior dose include nausea , vomit , abdominal pain distention . Subjects positive urine pregnancy test prior dose . Medication change within one month prior visit one . Corticosteroid use within 2 month prior visit one . Age &lt; 18 . Known intolerance lubiprostone . Inability perform require study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Constipation</keyword>
	<keyword>Multiple Sclerosis Associated Constipation</keyword>
</DOC>